Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | PACB |
---|---|---|
09:32 ET | 164427 | 1.81 |
09:33 ET | 61459 | 1.79 |
09:35 ET | 57169 | 1.7994 |
09:37 ET | 42925 | 1.798 |
09:39 ET | 11134 | 1.7992 |
09:42 ET | 42701 | 1.795 |
09:44 ET | 137949 | 1.78 |
09:46 ET | 59611 | 1.7885 |
09:48 ET | 79454 | 1.785 |
09:50 ET | 56481 | 1.7849 |
09:51 ET | 136628 | 1.7705 |
09:53 ET | 46489 | 1.79 |
09:55 ET | 28205 | 1.785 |
09:57 ET | 30932 | 1.7801 |
10:00 ET | 268136 | 1.7988 |
10:02 ET | 57345 | 1.7894 |
10:04 ET | 75312 | 1.7817 |
10:06 ET | 32460 | 1.78 |
10:08 ET | 21281 | 1.79 |
10:09 ET | 25069 | 1.7972 |
10:11 ET | 20484 | 1.78 |
10:13 ET | 10300 | 1.785 |
10:15 ET | 17754 | 1.795 |
10:18 ET | 14110 | 1.79 |
10:20 ET | 43671 | 1.795 |
10:22 ET | 37919 | 1.795 |
10:24 ET | 1385 | 1.795 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Pacific Biosciences of California Inc | 493.0M | -1.2x | --- |
Zynex Inc | 263.0M | 56.1x | +1.09% |
AxoGen Inc | 587.1M | -40.9x | --- |
Cytek Biosciences Inc | 843.7M | -82.9x | --- |
Quanterix Corp | 451.0M | -11.7x | --- |
LifeMD Inc | 249.8M | -9.7x | --- |
Pacific Biosciences of California, Inc. is a life science technology company. It is engaged in designing, developing, and manufacturing advanced sequencing solutions that enable scientists and clinical researchers to resolve genetically complex problems. Its products and technology under development stem from two differentiated core technologies, which include its HiFi long-read sequencing technology and its Sequencing by Binding (SBB) short-read sequencing technology. Its products address solutions across a set of applications, including human genetics, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. It has developed HiFi long-read sequencing based on Single-Molecule Real-Time technology, which accurately detects the nucleotide sequence and epigenetic status of individual DNA molecules. Its Revio, Sequel, Sequel II and Sequel IIe instruments conduct, monitor, and analyze single-molecule biochemical reactions in real time.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $493.0M |
---|---|
Revenue (TTM) | $173.1M |
Shares Outstanding | 273.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.95 |
EPS | $-1.46 |
Book Value | $2.62 |
P/E Ratio | -1.2x |
Price/Sales (TTM) | 2.8 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -236.12% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.